My Sanford Chart allows you secure online access to your personal health information and your child's health information. It's available anywhere you have internet access. There is no cost to you and registering is quick and simple.

Sign Up for My Sanford Chart
Study ID: CTSU R0815
Title:

Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

Description:

The purpose of this study is to compare the effects of dose-escalated radiation therapy with or without hormone therapy on prostate cancer participants. Participants in this study have been diagnosed with intermediate-risk prostate cancer. Prior studies have suggested possible advantages to the administration of hormonal therapy with radiation. However, those studies were performed with radiation techniques that do not match those commonly used in clinical practice today. Therefore, this study will be testing to see if similar benefits for hormonal therapy are seen when sued with current radiation therapy techniques. This study is testing whether the side effects of hormonal therapy are outweighed by an advantage in prostate cancer cure rates for patients receiving that treatment.

Location:
Bemidji Clinic, Bismarck Region, Fargo Region
Principal Investigator:
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
Prostate
Stage:
Phase III

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list